Showing results (191-200 of 351) with videos related to
Sort By:
Pageof 36
Frontiers in Nutrition|November 26, 2020
Comparative Effects of Intraduodenal Glucose and Fat Infusion on Blood Pressure and Heart Rate in Type 2 DiabetesCong Xie, Xuyi Wang, Karen L Jones, et al.International Journal of Obesity (2005)|November 15, 2016
Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjectsL G Trahair, C S Marathe, S Standfield, et al.Diabetes Care|February 16, 2019
Comparative Effects of Proximal and Distal Small Intestinal Glucose Exposure on Glycemia, Incretin Hormone Secretion, and the Incretin Effect in Health and Type 2 DiabetesXiang Zhang, Richard L Young, Michelle Bound, et al.Journal of Diabetes and Its Complications|June 13, 2024
Effect of lixisenatide on liquid gastric emptying in type 2 diabetes - Implications for the use of GLP-1 receptor agonists before proceduresJoshua G Kovoor, Christopher K Rayner, Tongzhi Wu, et al.Physiological Reports|February 16, 2018
Comparative effects of small intestinal glucose on blood pressure, heart rate, and noradrenaline responses in obese and healthy subjectsLaurence G Trahair, Tongzhi Wu, Christine Feinle-Bisset, et al.Diabetes, Obesity & Metabolism|October 30, 2018
Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetesMalcolm J Borg, Michelle Bound, Jacqueline Grivell, et al.Nutrition & Diabetes|May 19, 2015
Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy malesT Wu, S S Thazhath, C S Marathe, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 13, 2014
Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?T Wu, L G Trahair, M J Bound, et al.Diabetes, Obesity & Metabolism|November 7, 2019
Role of endogenous glucagon-like peptide-1 enhanced by vildagliptin in the glycaemic and energy expenditure responses to intraduodenal fat infusion in type 2 diabetesCong Xie, Xuyi Wang, Karen L Jones, et al.Diabetes, Obesity & Metabolism|July 3, 2024
Impairments of insulin and glucagon sensitivity in Chinese women with gestational diabetes mellitusDan Zhang, Jianan Zhu, Nicolai J Wewer Albrechtsen, et al.Pageof 36